SPROGOE KENNETT,CLEEMANN FELIX,HERSEL ULRICH,KADEN-VAGT SILVIA,LESSMANN TORBEN,RAU HARALD,WEGGE THOMAS
申请号：
TN2012000010
公开号：
TN2012000010A1
申请日:
2012.01.05
申请国别(地区):
TN
年份:
2013
代理人:
摘要：
The present invention relates to a pharmaceutical composition comprising an insulin compound in a concentration that is sufficient to maintain a therapeutically effective level of the insulin compound in blood plasma for at least 3 days characterized by having a pharmacokinetic profile in vivo with substantially no burst of the insulin compound. The present invention further relates to the use of an insulin compound for preparing said pharmaceutical composition as well as a kit of parts comprising said pharmaceutical composition.
